2 mg semaglutide to tirzepatide And Semaglutide: Experts Explain New Diabetes, Obesity Drug Options Why You Might Tolerate One

If you develop new symptoms suggestive of hyperglycaemia or your home glucose readings consistently exceed your target range, contact your GP or diabetes team promptly

40 Podocyte metabolism undergoes early shifts in DKD, with oxidative stress promoting podocyte apoptosis

Much like managing insulin therapy from a Read More GLP-1 Therapy Discontinuation: How to Identify Patients at Risk and Prevent Drop-Off May 5, 2026 Articles, Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Type 2 Diabetes, Type 2 Diabetes 996 views Discontinuation of GLP-1 therapy is becoming a growing concern in diabetes care, even though these treatments show strong clinical benefits

December 5, 2025